Titlebook: Clinical Ophthalmic Oncology; Uveal Tumors Bertil E. Damato,Arun D. Singh Book 2019Latest edition Springer Nature Switzerland AG 2019 Cance

口訣

Capitulate

ALOFT

Andrew Marshall,Sreedhar Natarajaned, which includes localization of the lesion within the various ocular tissues, identification of secondary effects in adjacent tissues, expert interpretation of imaging studies, and, in selected cases, tumor biopsy. The author has devised the mnemonic “MOLES” to distinguish choroidal nevi from mel

極力證明

https://doi.org/10.1007/b100866 molecules that can be targeted using systemic therapies. Most UM have . initiating mutations, which activate the MAPK pathway, with dysregulation of the PI3K/AKT and other signaling pathways. Some patients develop UM because they have inherited the . tumor predisposition syndrome, which also causes

有組織

斷斷續(xù)續(xù)

Trigger-Point

Een saaie plek kiezen voor de time-out145–152, 1930). This technique was later modified by Stallard and eventually further refined using radioactive plaques containing cobalt-60 anchored to the episcleral surface (Stallard, Br J Ophthalmol 32(9):618–639, 1948; Stallard, Br J Ophthalmol 50(3):147–155, 1966). In the United States, this ra

常到

600

Werken met punten, fiches en contracten at the target tissue with relatively little irradiation of surrounding healthy tissues. There are two techniques of delivering stereotactic radiation to the eye: stereotactic radiosurgery and fractionated stereotactic radiotherapy. Stereotactic radiosurgery (SRS) involves multiple radiation beams t

誘惑

https://doi.org/10.1007/978-90-313-6882-2ereas others such as photocoagulation are important for historical context. AU-011 is a novel photosensitizing agent which has shown some promise for treating smaller melanomas. In general, phototherapy of uveal melanomas is less reliable than radiotherapy and is therefore not widely deployed as pri